This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

10 Stocks That Could Rise in Market Decline

Stocks in this article: AMNMTBHIEXELGENHALNRGPTENSVNTUPL

5. NRG Energy (NRG)

Company profile: NRG, with a market value of $3.5 billion, is a wholesale power generation company that operates power generation facilities and sells energy.

Investor takeaway: Its shares are down 16% this year and have a three-year, average annual decline of 8%. Morningstar says its shares, now at $14.84, are trading at 43% of their fair-value estimate of $35. Analysts give its shares seven "buy" ratings, three "buy/holds," and five "holds," according to a survey of analysts by S&P.

4. Ultra Petroleum Corp. (UPL)

Company profile: Ultra, with a market value of $3 billion, is an independent oil and natural gas exploration and production company with operations from Wyoming and to Pennsylvania.

Investor takeaway: Its shares are down 30% this year and have a three-year, average annual loss of 20%. Morningstar says its shares, now trading at $20.17, are at 40% of their fair-value estimate of $50. Analysts give its shares five "buy" ratings, one "buy/holds," and 19 "holds," according to a survey of analysts by S&P.

3. Patterson-UTI Energy (PTEN)

Company profile: Patterson-UTI, with a market value of $2.6 billion, is North America's second largest operator of land-based drilling rigs.

Investor takeaway: Its shares are down 15% this year and have a three-year, average annual return of 17%. Morningstar says its shares, now trade at 39% of fair value of $43. Analysts give its shares nine "buy" ratings, eight "buy/holds," nine "holds," one "weak hold," and one "sell," according to a survey of analysts by S&P.

2. ArcelorMittal (MT)

Company profile: ArcelorMittal, with a market value of $28 billion, is the world's largest steel producer, with an established presence in all major steel markets and steelmaking operations in 20 countries

Investor takeaway: Its shares are down 1.8% this year and have a three-year, average annual decline of 7%. Morningstar says its shares, now at $17.60, are trading at 36% of its fair value estimate of $48. Analysts give its shares three "buy" ratings, three "buy/holds," and two "holds," according to a survey of analysts by S&P.

1. Savient Pharmaceuticals (SVNT)

Company profile: Savient, with a market value of $138 million, is a specialty biopharmaceutical company with one meaningful drug, Krystexxa, which treats chronic gout refractory to conventional therapy.

Investor takeaway: Its shares are down 9% this year and have a three-year, average annual loss of 26%. Morningstar says its shares, now at $1.92, are trading at 35% of their fair-value estimate of $5.50. Analysts give its shares one "buy" rating, six "holds," two "weak holds," and one "sell," according to a survey of analysts by S&P.

>>To see these stocks in action, visit the 10 Stocks That Could Rise in Market Decline portfolio on Stockpickr.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs